{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:13:32Z","timestamp":1737436412478,"version":"3.33.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Baoding City Key Laboratory of Diagnosis and Treatment of Pulmonary Nodules"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-024-03225-5","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T13:17:57Z","timestamp":1737379077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rivaroxaban versus low molecular weight heparin for managing lower extremity deep vein thrombosis following thoracoscopic lung cancer surgery: a randomized controlled trial"],"prefix":"10.1186","volume":"20","author":[{"given":"Lidan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"3225_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2011.07.004","volume":"75","author":"L Corrales-Rodriguez","year":"2012","unstructured":"Corrales-Rodriguez L, Blais N. Lung cancer associated venous thromboembolic disease: a comprehensive review. Lung Cancer. 2012;75:1\u20138.","journal-title":"Lung Cancer"},{"issue":"5","key":"3225_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","volume":"34","author":"A Falanga","year":"2023","unstructured":"Falanga A, Ay C, Di Nisio M, et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol. 2023;34(5):452\u201367. https:\/\/doi.org\/10.1016\/j.annonc.2022.12.014.","journal-title":"Ann Oncol"},{"key":"3225_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","volume":"162","author":"G Meyer","year":"2002","unstructured":"Meyer G, Marjanovic Z, Valcke J, et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med. 2002;162:1729\u201335.","journal-title":"Arch Intern Med"},{"key":"3225_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMoa1711948","volume":"378","author":"GE Raskob","year":"2018","unstructured":"Raskob GE, van Es N, Verhamme P, et al. Edoxaban for the treatment of Cancer-Associated venous thromboembolism. N Engl J Med. 2018;378:615\u201324.","journal-title":"N Engl J Med"},{"key":"3225_CR5","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","volume":"36","author":"AM Young","year":"2018","unstructured":"Young AM, Marshall A, Thirlwall J, et al. Comparison of an oral factor xa inhibitor with low Molecular Weight Heparin in patients with Cancer with venous thromboembolism: results of a Randomized Trial (SELECT-D). J Clin Oncol. 2018;36:2017\u201323.","journal-title":"J Clin Oncol"},{"key":"3225_CR6","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","volume":"382","author":"G Agnelli","year":"2020","unstructured":"Agnelli G, Becattini C, Meyer G, et al. Apixaban for the treatment of venous Thromboembolism Associated with Cancer. N Engl J Med. 2020;382:1599\u2013607.","journal-title":"N Engl J Med"},{"key":"3225_CR7","doi-asserted-by":"crossref","unstructured":"McBane RD 2nd, Wysokinski WE, Le-Rademacher JG, et al. Apixaban and dalteparin in active malignancy-associated venous thromboembolism: the ADAM VTE trial. J Thromb Haemost. 2020;18:411\u201321.","DOI":"10.1111\/jth.14662"},{"issue":"13","key":"3225_CR8","first-page":"653","volume":"46","author":"Tumor and Thrombosis Expert Committee of Chinese Society of Clinical Oncology","year":"2019","unstructured":"Tumor and Thrombosis Expert Committee of Chinese Society of Clinical Oncology. Guidelines for the prevention and treatment of cancer-associated venous thromboembolism. (2019 Edition). Chin J Clin Oncol. 2019;46(13):653\u201360.","journal-title":"Chin J Clin Oncol"},{"key":"3225_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1378\/chest.13-2379","volume":"146","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Yang Y, Chen W, et al. Prevalence and associations of VTE in patients with newly diagnosed lung cancer. Chest. 2014;146:650\u20138.","journal-title":"Chest"},{"key":"3225_CR10","doi-asserted-by":"publisher","first-page":"182521","DOI":"10.1155\/2009\/182521","volume":"2009","author":"IE Hall","year":"2009","unstructured":"Hall IE, Andersen MS, Krumholz HM, et al. Predictors of venous thromboembolism in patients with advanced common solid cancers. J Cancer Epidemiol. 2009;2009:182521.","journal-title":"J Cancer Epidemiol"},{"key":"3225_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.athoracsur.2013.10.074","volume":"97","author":"TD Christensen","year":"2014","unstructured":"Christensen TD, Vad H, Pedersen S, et al. Venous thromboembolism in patients undergoing operations for lung cancer: a systematic review. Ann Thorac Surg. 2014;97:394\u2013400.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"3225_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE Disease:CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315\u201352. https:\/\/doi.org\/10.1016\/j.chest.2015.11.026.","journal-title":"Chest"},{"issue":"3","key":"3225_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jaccao.2020.06.001","volume":"2","author":"J Sabatino","year":"2020","unstructured":"Sabatino J, De Rosa S, Polimeni A, et al. Direct oral anticoagulants in patients with active Cancer: a systematic review and Meta-analysis. JACC CardioOncol. 2020;2(3):428\u201340. https:\/\/doi.org\/10.1016\/j.jaccao.2020.06.001. PMID: 34396250; PMCID: PMC8352218.","journal-title":"JACC CardioOncol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-03225-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-024-03225-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-03225-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T13:18:01Z","timestamp":1737379081000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-024-03225-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3225"],"URL":"https:\/\/doi.org\/10.1186\/s13019-024-03225-5","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}